Libenzapril - CISMeF

Preferred Label : Libenzapril;

NCIt definition : A long-acting, small polar angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Libenzapril competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II and results in vasodilation. Libenzapril also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.;

UNII : QD8496WWYK;

InChIKey : AXTCRUUITQKBAV-KBPBESRZSA-N;

CAS number : 97878-35-8;

Chemical formula : C18H25N3O5;

Details

Origin ID

C81335;

UMLS CUI

C0055225;

Currated CISMeF NLP mapping
- libenzapril [MeSH concept]
- libenzapril [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- libenzapril [MeSH concept]
- libenzapril [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients